Kristin Nelson
Nurse Practitioner · Arlington Heights, ILNPI 1043778731
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.2% of the total across 490 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 38.3% of the total. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 490 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Pfizer$1K
- Lilly USA, LLC$1K
- Biohaven Pharmaceuticals, Inc.$934
- Lundbeck LLC$763
- Amgen$516
- plus $3K from 28 others
What the payments were for
- Consulting fees$8007%
- Food & beverage$11,10293%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 211 | $4,567 |
| Pfizer | 68 | $1,311 |
| Lilly USA, LLC | 34 | $1,024 |
| Biohaven Pharmaceuticals, Inc. | 9 | $934 |
| Lundbeck LLC | 24 | $763 |
| Amgen(2 entities) | 13 | $516 |
| Teva Pharmaceuticals USA, Inc. | 16 | $427 |
| Abbott | 6 | $351 |
| Impel Pharmaceuticals LLC | 15 | $295 |
| Biohaven Pharmaceutical Holding Company Ltd. | 16 | $255 |
| Axsome Therapeutics, Inc. | 8 | $233 |
| Almatica Pharma LLC | 16 | $195 |
| Neurocrine Biosciences, Inc. | 6 | $133 |
| Novartis | 4 | $91 |
| Tonix Medicines, Inc. | 5 | $90 |
| Scilex Pharmaceuticals Inc. | 3 | $85 |
| Johnson & Johnson(2 entities) | 3 | $78 |
| IBSA Pharma Inc. | 5 | $78 |
| Idorsia Pharmaceuticals US Inc | 5 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Fidia Pharma USA Inc. | 3 | $53 |
| Arbor Pharmaceuticals, Inc. | 3 | $45 |
| Impel Pharmaceuticals Inc. | 2 | $40 |
| Medtronic | 2 | $35 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Avanos Medical | 1 | $22 |
| Merck | 1 | $22 |
| Bausch Health US, LLC | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Orthogenrx Inc. | 1 | $17 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,909 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| UbrelvyUbrogepant | 29 | $53,046 |
| Nurtec OdtRimegepant Sulfate | 28 | $52,077 |
| ReyvowLasmiditan Succinate | 24 | $25,569 |
| QuliptaAtogepant | 20 | $23,565 |
| ZavzpretZavegepant Hcl | 17 | $18,521 |
| BelsomraSuvorexant | 27 | $14,119 |
| Emgality PenGalcanezumab-Gnlm | 14 | $12,220 |
| Lacosamide | 82 | $2,851 |
| Diphenhydramine Hcl | 54 | $1,495 |
| Candesartan Cilexetil | 19 | $1,223 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 29 | $1,201 |
| Doxepin Hcl | 29 | $805 |
| Lidocaine | 15 | $762 |
| Nebivolol Hcl | 12 | $686 |
| Chlorpromazine Hcl | 19 | $671 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $4,567 | $76,61149 claims |
| PfizerNurtec Odt, Zavzpret | $1,311 | $70,59845 claims |
| Lilly USA, LLCReyvow, Olanzapine | $1,024 | $25,72258 claims |
| MerckBelsomra | $22 | $14,11927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Arlington Heights
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
- Kristine WarnesNaperville$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.